Here are San Diego’s top 10 first-quarter deals, based on PitchBook data from the Venture Monitor report.
| Vividion Therapeutics | $50 million | BioPharma |
| F1 Oncology | $44 million | Anti-cancer |
| Biological Dynamics | $28.9 million | Anti-cancer |
| Dauntless Pharmaceuticals | $25 million | BioPharma |
| Jecure Therapeutics | $20 million | BioPharma |
| Neurelis | $20 million | BioPharma |
| Oncternal Therapeutics | $18.4 million | Anti-cancer |
| Genoa Pharmaceuticals | $16.6 million | BioPharma |
| Avidity Biosciences | $16 million | BioPharma |
| Echo Laboratories | $12.9 million | Healthtech |
via First-Quarter Venture Funding Slumps in San Diego, and Top 10 Deals | Xconomy
